The impact of rapid atrial pacing on ADMA and endothelial NOS

International Journal of Cardiology

Volumn 154, Issue 2, 2012, Pages 141-146

  Goette, Andreas ^a   Hammwöhner, Matthias ^a   Bukowska, Alicja ^a   Scalera, Fortunato ^a   Martens Lobenhoffer, Jens ^a   Dobrev, Dobromir ^b,d   Ravens, Ursula ^b   Weinert, Soenke ^a   Medunjanin, Senad ^a   Lendeckel, Uwe ^c   Bode Böger, Stefanie M ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c UNIVERSITY OF GREIFSWALD   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Asymmetric dimethylarginine; Atrial fibrillation; Calcium; Endothelium; Rapid atrial pacing; Vasoreactivity

Indexed keywords

CALCIUM ION; CYCLIC AMP DEPENDENT PROTEIN KINASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; MESSENGER RNA; N(G),N(G) DIMETHYLARGININE; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE;

ADULT; ANIMAL EXPERIMENT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DOWN REGULATION; ENDOTHELIUM CELL; FEMALE; HEART ATRIUM FIBRILLATION; HEART ATRIUM PACING; HEART MUSCLE CONTRACTILITY; HEMODYNAMICS; HUMAN; HUMAN CELL; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SINUS RHYTHM;

AGED; ANIMALS; ARGININE; ATRIAL FIBRILLATION; CALCIUM-BINDING PROTEINS; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; FEMALE; HEART RATE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; NITRIC OXIDE SYNTHASE TYPE III; OXIDATIVE STRESS; PACEMAKER, ARTIFICIAL; RISK FACTORS; SWINE; TACHYCARDIA; VENTRICULAR FUNCTION, LEFT;

EID: 84855831160     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2010.09.004     Document Type: Article

References (38)

1. D.G. Wyse, A.L. Waldo, and J.P. DiMarco A comparison of rate control and rhythm control in patients with atrial fibrillation N Engl J Med 347 2002 1825 1833 (Pubitemid 35417773)
2. I.C. Van Gelder, V.E. Hagens, and H.A. Bosker Rate Control versus Electrical Cardioversion for Persistent Atrial Fibrillation Study Group. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation N Engl J Med 347 2002 1834 1840 (Pubitemid 35417774)
3. G.E. Kochiadakis, E.I. Skalidis, and M.D. Kalebubas Effect of acute atrial fibrillation on phasic coronary blood flow pattern and flow reserve in humans Eur Heart J 23 2002 734 741 (Pubitemid 35230704)
4. A.M. Brown, K.L. Sease, J.L. Robey, F.S. Shofer, and J.E. Hollander The risk for acute coronary syndrome associated with atrial fibrillation among ED patients with chest pain syndromes Am J Emerg Med 25 2007 523 528 (Pubitemid 46824166)
5. A. Goette, A. Bukowska, and D. Dobrev Acute atrial tachyarrhythmia induces angiotensin II type 1 receptor mediated oxidative stress and microvascular flow abnormalities in the ventricles Eur Heart J 30 2009 1411 1420
6. R.H. Boger, S.M. Bode-Boger, and A. Szuba Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia Circulation 98 1998 1842 1847 (Pubitemid 28509278)
7. S.M. Bode-Böger, F. Scalera, and L.J. Ignarro The l-arginine paradox: importance of the l-arginine/asymmetrical dimethylarginine ratio Pharmcol Ther 114 2007 295 306 (Pubitemid 46843253)
8. H. Miyazaki, H. Matsuoka, and J.P. Cooke Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis Circulation 99 1999 1141 1146 (Pubitemid 29120084)
9. Q. Feng, X. Lu, and A.J. Fortin Elevation of an endogenous inhibitor of nitric oxide synthesis in experimental congestive heart failure Cardiovasc Res 37 1998 667 675 (Pubitemid 28231161)
10. M. Saitoh, T. Osanai, and T. Kamada High plasma level of asymmetric dimethylarginine in patients with acutely exacerbated congestive heart failure: role in reduction of plasma nitric oxide level Heart Vessels 18 2003 177 182 (Pubitemid 37258670)
11. M.C. Stuhlinger, R.K. Oka, and E.E. Graf Endothelial dysfunction induced by hyperhomocyst(e)inemia: role of asymmetric dimethylarginine Circulation 108 2003 933 938 (Pubitemid 37048221)
12. K. Hasegawa, S. Wakino, and S. Tatematsu Role of asymmetric dimethylarginine in vascular injury in transgenic mice overexpressing dimmethylarginine dimethylaminohydrolase 2 Circ Res 1001 2007 e2 e10
13. O. Suda, M. Tsutsui, and T. Morishita Asymmetric dimethylarginine produces vascular lesions in endothelial nitric oxide synthase-deficient mice: involvement of renin-angiotensin system and oxidative stress Arterioscler Thromb Vasc Biol 24 2004 1682 1688 (Pubitemid 39180895)
14. A. Meinitzer, U. Seelhorst, and B. Wellnitz Asymmetrical dimethylarginine independently predicts total and cardiovascular mortality in individuals with angiographic coronary artery disease (The Ludwigshafen risk and cardiovascular health study) Clin Chem 53 2007 273 283 (Pubitemid 46338272)
15. M. Hammwöhner, A. Ittenson, and J. Dierkes Platelet expression of CD40/CD40 ligand and its relation to inflammatory markers and adhesion molecules in patients with atrial fibrillation Exp Biol Med 232 2007 581 589 (Pubitemid 46524481)
16. J. Martens-Lobenhoffer, and S.M. Bode-Böger Fast and efficient determination of arginine, symmetric dimethylarginine, and asymmetric dimethylarginine in biological fluids by hydrophilic interaction liquid chromatography-electrospray tandem mass spectrometry Clin Chem 52 2006 488 493
17. D. Tsikas Simultaneous derivatization and quantification of the nitric oxide metabolites nitrite and nitrate in biological fluids by gas chromatography/mass spectrometry Anal Chem 72 2000 4064 4072
18. A. Goette, A. Bukowska, and U. Lendeckel Angiotensin II receptor blockade reduces tachycardia-induced atrial adhesion molecule expression Circulation 117 2008 732 742 (Pubitemid 351640674)
19. F. Scalera, J. Kielstein, J. Martens-Lobenhoffer, S. Postel, M. Täger, and S.M. Bode-Böger Erythropoietin increases asymmetric dimethylarginine in endothelial cells - role of dimethylarginine dimethylaminohydrolase J Am Soc Nephrol 16 2005 892 898 (Pubitemid 41710299)
20. A. Bukowska, U. Lendeckel, and D. Hirte Activation of the calcineurin signaling pathway induces atrial hypertrophy during atrial fibrillation Cell Mol Life Sci 63 2006 333 342 (Pubitemid 43202314)
21. J.S. Shinbane, M.A. Wood, D.N. Jensen, K.A. Ellenbogen, A.P. Fitzpatrick, and M.M. Scheinman Tachycardia-induced cardiomyopathy: a review of animal models and clinical studies J Am Coll Cardiol 29 1997 709 715 (Pubitemid 27128241)
22. D.M. Bers Altered cardiac myocyte Ca regulation in heart failure Physiology (Bethesda) 21 2006 380 387 (Pubitemid 44879246)
23. Y. Miyasaka, M.E. Barnes, and B.J. Gersh Coronary ischemic events after first atrial fibrillation: risk and survival Am J Med 120 2007 357 363
24. A. El-Armouche, L. Pohlmann, and S. Schlossarek Decreased phosphorylation levels of cardiac myosin-binding protein-C in human and experimental heart failure J Mol Cell Cardiol 43 2007 223 229 (Pubitemid 47079047)
25. A. Cengel, A. Sahinarslan, and G. Biberoǧlu Asymmetrical dimethylarginine level in atrial fibrillation Acta Cardiol 63 1 2008 33 37 (Pubitemid 351262964)
26. W. Xia, Z. Yin, J. Li, Y. Song, and X. Qu Effects of rosuvastatin on asymmetric dimethylarginine levels and early atrial fibrillation recurrence after electrical cardioversion Pacing Clin Electrophysiol 32 12 2009 1562 1566
27. R.J. Nijveldt, M.P. Siroen, T. Teerlink, and P.A. van Leeuwen Elimination of asymmetric dimethylarginine by the kidney and the liver: a link to the development of multiple organ failure? J Nutr 134 10 Suppl 2004 2848S 2852S (Pubitemid 39315234)
28. R.J. Nijveldt, T. Teerlink, and B. Van Der Hoven Asymmetrical dimethylarginine (ADMA) in critically ill patients: high plasma ADMA concentration is an independent risk factor of ICU mortality Clin Nutr 22 2003 23 30 (Pubitemid 36193177)
29. E.J. Benjamin, P.A. Wolf, R.B. D'Agostino, H. Silbershatz, W.B. Kannel, and D. Levy Impact of atrial fibrillation on the risk of death: the Framingham Heart Study Circulation 98 1998 946 952 (Pubitemid 28446646)
30. D.L. Dries, D.V. Exner, B.J. Gersh, M.J. Domanski, M.A. Waclawiw, and L.W. Stevenson Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials J Am Coll Cardiol 32 1998 695 703 (Pubitemid 28435256)
31. H. Liu, X. Qu, Z. Liang, W. Chen, W. Xia, and Y. Song Variance of DDAH/PRMT/ADMA pathway in atrial fibrillation dogs Biochem Biophys Res Commun 377 2008 884 888
32. P. Nerheim, S. Birger-Botkin, L. Piracha, and B. Olshansky Heart failure and sudden death in patients with tachycardia-induced cardiomyopathy and recurrent tachycardia Circulation 110 2004 247 252 (Pubitemid 38960795)
33. N. Akoum, and M.H. Hamdan Atrial fibrillation and congestive heart failure: a two-way street Curr Heart Fail Rep 4 2007 78 83 (Pubitemid 46954735)
34. R.A. Kelly, J.L. Balligand, and T.W. Smith Nitric oxide and cardiac function Circ Res 79 1996 363 380 (Pubitemid 26276897)
35. D. Fraccarollo, J.D. Widder, and P. Galuppo Improvement in left ventricular remodeling by the endothelial nitric oxide synthase enhancer AVE9488 after experimental myocardial infarction Circulation 118 2008 818 827
36. S.J. Nicholls, Z. Wang, and R. Koeth Metabolic profiling of arginine and nitric oxide pathways predicts hemodynamic abnormalities and mortality in patients with cardiogenic shock after acute myocardial infarction Circulation 116 2007 2315 2324 (Pubitemid 350100338)
37. T. Minamino, M. Kitakaze, and H. Sato Plasma levels of nitrite/nitrate and platelet cGMP levels are decreased in patients with atrial fibrillation Arterioscler Thromb Vasc Biol 17 1997 3191 3195 (Pubitemid 28016076)
38. A.J. Coats Ethical authorship and publishing Int J Cardiol 131 2009 149 150